An ingredient under fire. Drugmakers are jittery after an FDA panel ruling.
Year: 2000
Type: other
Source: PubMed
Author: D Noonan
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2412598044
